According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...
On January 6, 2025, the FDA released draft guidance on using artificial intelligence (AI) in regulatory decision-making for ...
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...
The Hims & Hers version of the weight-loss drug is a compounded drug, essentially a mixture of individual drugs that creates ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback